Literature DB >> 18390481

Musculoskeletal desmoid tumors.

Harish S Hosalkar1, Jesse T Torbert, Edward J Fox, Thomas F Delaney, Albert J Aboulafia, Richard D Lackman.   

Abstract

Desmoid tumors are benign tumors that exhibit varying degrees of local aggressiveness and diverse growth patterns. Magnetic resonance imaging remains the modality of choice for assessment of the nature and size of the soft-tissue lesion and involvement of surrounding structures. Treatment strategies include surgery, chemotherapy, hormonal therapy, and radiation therapy, either individually or in combination. Despite the benign nature of these tumors, multidisciplinary care is needed to provide combined treatment options. Chemotherapy in low doses is an excellent first-round treatment in any patient in whom contemplated local treatment may produce local morbidity and adjacent tissue injury.

Entities:  

Mesh:

Year:  2008        PMID: 18390481     DOI: 10.5435/00124635-200804000-00002

Source DB:  PubMed          Journal:  J Am Acad Orthop Surg        ISSN: 1067-151X            Impact factor:   3.020


  18 in total

1.  Signal transduction pathway analysis in fibromatosis: receptor and nonreceptor tyrosine kinases.

Authors:  Justin M M Cates; Jennifer O Black; Doha M Itani; John H Fasig; Vicki L Keedy; Kenneth R Hande; Brent W Whited; Kelly C Homlar; Jennifer L Halpern; Ginger E Holt; Herbert S Schwartz; Cheryl M Coffin
Journal:  Hum Pathol       Date:  2012-04-18       Impact factor: 3.466

2.  Prognostic factors in desmoid tumours: an example of translational oncology.

Authors:  Soledad Gallego Melcón
Journal:  Clin Transl Oncol       Date:  2011-03       Impact factor: 3.405

3.  Contralateral recurrence of aggressive fibromatosis in a young woman: A case report and review of the literature.

Authors:  Christopher J Schmoyer; Harmar D Brereton; Eric W Blomain
Journal:  Oncol Lett       Date:  2015-05-18       Impact factor: 2.967

4.  Extra-abdominal desmoid tumor with osseous involvement.

Authors:  Yaseen Oweis; David R Lucas; Catherine J Brandon; Gandikota Girish; Jon A Jacobson; David P Fessell
Journal:  Skeletal Radiol       Date:  2011-12-31       Impact factor: 2.199

5.  Clinical outcomes of systemic therapy for patients with deep fibromatosis (desmoid tumor).

Authors:  Veridiana Pires de Camargo; Mary L Keohan; David R D'Adamo; Cristina R Antonescu; Murray F Brennan; Samuel Singer; Linda S Ahn; Robert G Maki
Journal:  Cancer       Date:  2010-05-01       Impact factor: 6.860

Review 6.  Periosteal desmoplastic fibroma of the tibia in a 3-year-old child.

Authors:  N K Sferopoulos
Journal:  Eur J Orthop Surg Traumatol       Date:  2015-08-12

7.  FAP-associated desmoid invasiveness correlates with in vitro resistance to doxorubicin.

Authors:  David E Joyner; Sylvia H Trang; Albert J Aboulafia; Timothy A Damron; R L Randall; R Lor Randall
Journal:  Fam Cancer       Date:  2009       Impact factor: 2.375

8.  Extra-abdominal desmoid tumours: a review of the literature.

Authors:  A P Molloy; B Hutchinson; G C O'Toole
Journal:  Sarcoma       Date:  2012-08-16

9.  Treatment of extra - abdominal desmoid tumors with chemotherapy.

Authors:  Corey Montgomery; Cynthia Emory; Sheila Adams; Jonathan Cohen; John David Pitcher; Benjamin Kyle Potter; H Thomas Temple
Journal:  Cancers (Basel)       Date:  2011-08-25       Impact factor: 6.639

10.  Imaging features of superficial and deep fibromatoses in the adult population.

Authors:  Eric A Walker; Jonelle M Petscavage; Pamela L Brian; Chika Iloanusi Logie; Kenneth M Montini; Mark D Murphey
Journal:  Sarcoma       Date:  2012-06-28
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.